Navigation Links
Hunger hormone: Makes food more attractive

This release is available in French.

A new brain-imaging study by researchers at the Montreal Neurological Institute, McGill University reveals that ghrelin - a stomach hormone, acts on specific regions of the brain to enhance our response to food related cues and eating for pleasure. This study, published in the May 7 issue of Cell Metabolism, is critical to advance understanding and treating obesity, a condition affecting millions world-wide.

Appetite was previously thought of as being controlled by two separate mechanisms: homeostatic and non-homeostatic or hedonic food consumption. Homeostatic feeding is controlled by hormones such as ghrelin, that act on the brain to tell the body when to eat in an attempt to keep a constant body weight. Hedonic consumption is triggered by visual or smell cues. For example, wanting to eat a piece of cake just because it looks good and will bring pleasure when eaten. This study demonstrates that both food consumption behaviours are inter-connected and a key player in their regulation is the stomach hormone ghrelin.

Our study demonstrates that ghrelin actually activates certain regions of the brain to be more responsive to visual food cues, thereby enhancing the hedonic and incentive responses to food-related cues, says Dr. Alain Dagher, neurologist at the Montreal Neurological Institute, McGill University and principal investigator in the study. Ghrelin is a hormone that triggers hunger, and is secreted by the stomach [when it is empty]. An easy analogy would be to think about when you go shopping on an empty stomach, you tend to buy more food and products higher in calories. The reason is that your brain views the food as more appealing, largely due to the action of ghrelin on the brain.

The study supports the view that obesity must be understood as a brain disease and that hunger should also be looked at as a kind of food addiction. Obese individuals may eat too much largely due to excess hunger. Dr. Dagher and colleagues found that ghrelin worked on regions of the brain known to be involved with reward and motivation, the same regions implicated in drug addiction the amygdala, insula, the orbitofrontal cortex (OFC) and striatum. These areas work together to assign incentive value to objects in the world and to actions, and exert very powerful control over our behavior. They are all targets of addictive drugs (like cocaine and nicotine), and are also targets of feeding signals like ghrelin, explains Dr. Dagher.

Participants in the study were shown images of food and scenery [as a control] before and after receiving ghrelin intravenously during functional magnetic resonance imaging (fMRI). In addition to analyzing the activation of different brain regions, subjects also answered questions about their mood and appetite before and after seeing sets of images. The effects of ghrelin on the amygdala and OFC correlated with the self-rated hunger ratings.

This study has shown that ghrelin action is more complex than previously thought and furthers our understanding of how drug treatment might be used to combat obesity. This research may also inform public policy. If food is thought of as potentially addictive, this would support action to limit or ban fast food from schools and junk food advertisements geared towards children, in the same way that results proving nicotine to be addictive spurred the current public policy towards nicotine


Contact: Anita Kar
Montreal Neurological Institute and Hospital

Related biology news :

1. Norman Borlaug, Rob Horsch to keynote world hunger lecture
2. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
3. New drug makes weight loss safer
4. How mother of thousands makes plantlets
5. For honey bee queens, multiple mating makes a difference
6. Scientists spy enzyme that makes us unique
7. Thinking makes it so: Science extends reach of prosthetic arms
8. Choosing dry or wet food for cats makes little difference
9. Technique controls nanoparticle size, makes large numbers
10. Decoy makes sitting duck of superbugs
11. Case researcher in RNA biology makes waves by challenging current thinking
Post Your Comments:
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/26/2015)... PUNE, India , October 26, ... --> --> ... Forecasts 2015 to 2021 as well ... Analysis 2015-2019 research reports to its ... . ...
(Date:10/23/2015)... GOLETA, California , October 23, 2015 ... and SensoMotoric Instruments (SMI) announce a mobile plug and ... captured during interactive real-world tasks SensoMotoric Instruments ... of their established wearable solutions for eye tracking and ... behavior captured with SMI Eye Tracking Glasses 2w ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... ... 25, 2015 , ... Jessica Richman and Zachary Apte, founders ... initial angel funding process. Now, they are paying it forward to other microbiome ... investments in the microbiome space. In this, they join other successful entrepreneurs-turned-angels ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
Breaking Biology Technology: